These lesions can occur in patients with or without Tuberous Sclerosis Complex (TSC) and are driven by mutations in the TSC1 and TSC2 genes, which encode for hamartin and tuberin [68,69,70,71]. This evidence concerns the gene TSC1 and tuberous sclerosis.